This inventor holds 1 USPTO granted patent. Top assignees: Merck + Co., Inc., University of Washington. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4,770 
1 out of 2,174 
Years Active: 2012
Title: Andranik Andrew Aprikyan: Innovator in Neutropenia Treatment
Introduction
Andranik Andrew Aprikyan is a notable inventor based in Kenmore, WA (US). He has made significant contributions to the field of medicine, particularly in the treatment of inherited severe neutropenia. His innovative approach has the potential to improve the lives of patients suffering from this condition.
Latest Patents
Aprikyan holds a patent for a method of treating inherited severe neutropenia. This invention is specifically directed towards treating cyclic neutropenia (CN) or severe congenital neutropenia (SCN). The method involves administering a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof. This patent highlights his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Aprikyan has worked with prominent organizations such as Merck & Company, Inc. and the University of Washington. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include David C. Dale and Paul E. Finke. Their collaboration has likely enriched the research environment and fostered innovative solutions in the medical field.
Conclusion
Andranik Andrew Aprikyan's work in developing treatments for severe neutropenia showcases his dedication to medical innovation. His contributions are vital in the ongoing quest to improve patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile